Sign In
Buy TMO
$473.95
-8.13 (-1.69%)
At Close: Jun 03, 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the findings of new research by the Tufts Center for the Study of Drug Development
Report: Biotech Research Firm Thermo Fisher Considers Selling Diagnostics Business
01:05pm, Friday, 13'th Jun 2025
Biotechnology research firm Thermo Fisher Scientific is reportedly looking to sell part of its diagnostics business amid industrywide concerns about federal cutbacks in spending on research.
Thermo Fisher Stock Hurt by Macroeconomic Woes, Tough Competition
12:26pm, Friday, 13'th Jun 2025
TMO grapples with macro pressures, rising expenses and fierce competition, but bets on acquisitions to fuel recovery.
Ethris Signs Strategic Collaboration with Thermo Fisher Scientific to Provide Access to mRNA Technology Platforms
06:00am, Friday, 13'th Jun 2025
MUNICH--(BUSINESS WIRE)--Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced a strategic collaboration with Thermo Fisher Scie
Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports
07:54pm, Thursday, 12'th Jun 2025
Thermo Fisher Scientific plans to sell its diagnostics unit for about $4 billion in an attempt to offload some of its low-growth assets, the Financial Times reported on Thursday, citing people familia
TMO Launches Next-Generation Mass Spectrometers: Stock to Gain?
11:11am, Tuesday, 03'rd Jun 2025
Thermo Fisher debuts two advanced MSs, Orbitrap Astral Zoom and Orbitrap Excedion Pro, to accelerate precision medicine and drug discovery breakthroughs.
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the launch of the Thermo Scientific™ Orbitrap™ Astral™ Zoom mass
Thermo Fisher: With A 30% Price Drop, Trump Legislation, And High Capex, Is It Undervalued?
04:12am, Monday, 02'nd Jun 2025
The neutral DCF model implemented in this article suggests that Thermo Fisher is undervalued by 29.24%. Thermo Fisher has invested, on average, 16.51% of its revenues in capex between 2019 and 2024. D
Thermo Fisher Is Strengthening Its Long-Term Advantage
10:10pm, Sunday, 01'st Jun 2025
Thermo Fisher's 2025 headwinds from tariffs and US research funding cuts are real but temporary, not reflective of structural weakness in its fundamentals. The company is mitigating trade impacts by i
So Cheap It's Silly - 2 Dividend Stocks I'd Buy Twice If I Could
07:30am, Saturday, 31'st May 2025
Market extremes often drive flawed narratives. Many investors get spooked by sell-offs or seduced by overvaluations, when real opportunity hides in discomfort. While today's market isn't euphoric, it'
Thermo Fisher Launches New Spectral Flow Cytometer: Stock to Gain?
09:20am, Friday, 30'th May 2025
TMO unveils spectral-enabled Attune Xenith Flow Cytometer to streamline workflows and boost research accuracy.
3 Hedge Fund Favorite Stocks Trading At Yearly Low Prices
08:52am, Thursday, 29'th May 2025
KHC, CVX, and TMO stand out as some of the hardest-hit names held by big-name hedge funds.
Thermo Fisher Scientific Launches New Spectral Flow Cytometer Offering Increased Speed, Versatility and Reliability to Labs
08:30am, Thursday, 29'th May 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today launched the spectral-enabled Invitrogen™ Attune™ Xenith™ Flow Cytometer, allowing immu
Thermo Fisher Scientific Stock: Big Upside Potential After Sluggishness Through November?
09:30am, Wednesday, 28'th May 2025
Thermo Fisher Scientific Inc. TMO is currently navigating a rare and telling phase in its journey through the Adhishthana Cycle. The stock is in its 18th Phase, simultaneously on both the weekly and m
Thermo Fisher Scientific Celebrates Precision Oncology Advancement at ASCO 2025
08:30am, Wednesday, 28'th May 2025
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, will showcase some of the technologies that have helped power precision oncology at the 2025 American
